Rapt Therapeutics Inc
(RAPT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -129,865 | -116,798 | -83,838 | -69,204 | -52,892 |
| Depreciation Amortization | -1,610 | -4,520 | 751 | 2,266 | 1,620 |
| Other Working Capital | 25,907 | 5,499 | -1,335 | -4,298 | 2,344 |
| Other Operating Activity | 22,271 | 18,771 | 13,651 | 10,210 | 8,437 |
| Operating Cash Flow | $-83,297 | $-97,048 | $-70,771 | $-61,026 | $-40,491 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -82,218 | -161,497 | -190,856 | -164,977 | -139,334 |
| PPE Investments | -122 | -1,125 | -845 | -755 | -398 |
| Purchase Of Investment | 135,042 | 266,755 | 146,211 | 84,385 | 52,297 |
| Investing Cash Flow | $52,702 | $104,133 | $-45,490 | $-81,347 | $-87,435 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 152,852 | 1,447 | 131,180 | 141,482 | 75,461 |
| Financing Cash Flow | $152,852 | $1,447 | $131,180 | $141,482 | $75,461 |
| Beginning Cash Position | 47,478 | 38,946 | 24,027 | 24,918 | 77,383 |
| End Cash Position | 169,735 | 47,478 | 38,946 | 24,027 | 24,918 |
| Net Cash Flow | $122,257 | $8,532 | $14,919 | $-891 | $-52,465 |
| Free Cash Flow | |||||
| Operating Cash Flow | -83,297 | -97,048 | -70,771 | -61,026 | -40,491 |
| Capital Expenditure | -122 | -1,125 | -845 | -755 | -398 |
| Free Cash Flow | -83,419 | -98,173 | -71,616 | -61,781 | -40,889 |